Genprex, Inc. (GNPX) stock
GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.67−0.23 (-12.08%)
Close on Nov 17, 2026Market cap $1.37MP/E –Yield –
Genprex market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Genprex's market cap was $1.16M on Nov 11, 2026, against $65.40M a year earlier. Over the last 5 years it ranged from $1.13M to $2.40B, with a median of $131.64M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.16M | -97.0% |
| 2025 | Dec 31, 2025 | $38.67M | -62.4% |
| 2024 | Dec 31, 2024 | $102.85M | -65.8% |
| 2023 | Dec 29, 2023 | $300.75M | -80.4% |
| 2022 | Dec 30, 2022 | $1.53B | +11.2% |
| 2021 | Dec 31, 2021 | $1.38B | -61.8% |
| 2020 | Dec 31, 2020 | $3.60B | +3130.6% |
| 2019 | Dec 31, 2019 | $111.54M | -69.4% |
| 2018 | Dec 31, 2018 | $364.78M | – |
See a number that looks wrong?